Shandong Net Income From Continuing Ops from 2010 to 2024
| 600529 Stock | 24.52 0.31 1.28% |
Net Income From Continuing Ops | First Reported 2018-06-30 | Previous Quarter 220.8 M | Current Value 254.4 M | Quarterly Volatility 43.9 M |
Check Shandong Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shandong Pharmaceutical's main balance sheet or income statement drivers, such as Interest Expense of 215.5 K, Selling General Administrative of 177.4 M or Total Revenue of 5.2 B, as well as many indicators such as . Shandong financial statements analysis is a perfect complement when working with Shandong Pharmaceutical Valuation or Volatility modules.
Shandong | Net Income From Continuing Ops |
Currently Active Assets on Macroaxis
Other Information on Investing in Shandong Stock
Shandong Pharmaceutical financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Pharmaceutical security.